Analysis, BioTech, Health Policy and Medicare

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Analysis

BioTech

Health Policy

Medicare

The Healthcare and Macro-Economic Impacts of Living with Endemic COVID – Listening to Fitch

Health Populi

JUNE 24, 2021

We also expect innovation to come out of pharma and biotech labs, and who will pay for new-new therapies? For Medicare Part B programs alone, the drug could consume one-half of the total $57 billion of medicines spending… as much as the U.S. spends on NASA.

BioTech

BioTech Pharmaceuticals Public Health Telehealth

Most Americans Across Party ID Favor U.S. Government Negotiation to Lower Rx Drug Costs

Health Populi

MARCH 6, 2019

is prescription drug prices — that they’re too high, that the Federal government should negotiate to lower costs for Medicare enrollees, and that out-of-pocket costs for drugs should be limited. One of the only issues bringing people together in the U.S. “Humalog isn’t thirteen times as effective as it used to be.

Pharmaceuticals

Pharmaceuticals Life Science Medicare BioTech

Connected Health Pulse

The Healthcare and Macro-Economic Impacts of Living with Endemic COVID – Listening to Fitch

Most Americans Across Party ID Favor U.S. Government Negotiation to Lower Rx Drug Costs

Stay Connected